Bank of America’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-90,600
| Closed | -$10.1M | – | 7742 |
|
|
2025
Q3 | $10.1M | Buy |
90,600
+31,100
| +52% | +$3.53M | ﹤0.01% | 3303 |
|
|
2025
Q2 | $6.6M | Sell |
59,500
-112,700
| -65% | -$12M | ﹤0.01% | 3623 |
|
|
2025
Q1 | $19.3M | Sell |
172,200
-44,500
| -21% | -$4.59M | ﹤0.01% | 2474 |
|
|
2024
Q4 | $20M | Buy |
216,700
+62,500
| +41% | +$5.63M | ﹤0.01% | 2299 |
|
|
2024
Q3 | $12.9M | Sell |
154,200
-2,400
| -2% | -$183K | ﹤0.01% | 2826 |
|
|
2024
Q2 | $10.7M | Sell |
156,600
-112,800
| -42% | -$7.53M | ﹤0.01% | 2882 |
|
|
2024
Q1 | $19.7M | Sell |
269,400
-62,600
| -19% | -$4.81M | ﹤0.01% | 2299 |
|
|
2023
Q4 | $26.9M | Buy |
332,000
+81,700
| +33% | +$6.36M | ﹤0.01% | 1866 |
|
|
2023
Q3 | $18.8M | Buy |
250,300
+33,900
| +16% | +$2.61M | ﹤0.01% | 2089 |
|
|
2023
Q2 | $16.7M | Sell |
216,400
-73,800
| -25% | -$5.89M | ﹤0.01% | 2194 |
|
|
2023
Q1 | $24.1M | Sell |
290,200
-225,600
| -44% | -$18.7M | ﹤0.01% | 1955 |
|
|
2022
Q4 | $44.3M | Buy |
515,800
+4,300
| +0.8% | +$341K | 0.01% | 1385 |
|
|
2022
Q3 | $31.6M | Buy |
511,500
+87,700
| +21% | +$5.53M | ﹤0.01% | 1604 |
|
|
2022
Q2 | $26.2M | Sell |
423,800
-915,100
| -68% | -$56.7M | ﹤0.01% | 1777 |
|
|
2022
Q1 | $79.6M | Buy |
1,338,900
+192,500
| +17% | +$12.3M | 0.01% | 1077 |
|
|
2021
Q4 | $83.2M | Buy |
1,146,400
+421,900
| +58% | +$29.1M | 0.01% | 1084 |
|
|
2021
Q3 | $50.6M | Buy |
724,500
+313,400
| +76% | +$22M | 0.01% | 1347 |
|
|
2021
Q2 | $28.3M | Sell |
411,100
-37,800
| -8% | -$2.52M | ﹤0.01% | 1818 |
|
|
2021
Q1 | $29M | Sell |
448,900
-89,000
| -17% | -$5.74M | ﹤0.01% | 1710 |
|
|
2020
Q4 | $31.3M | Buy |
537,900
+216,700
| +67% | +$13.1M | ﹤0.01% | 1517 |
|
|
2020
Q3 | $20.3M | Sell |
321,200
-336,800
| -51% | -$23.4M | ﹤0.01% | 1695 |
|
|
2020
Q2 | $50.6M | Sell |
658,000
-212,000
| -24% | -$16.2M | 0.01% | 1016 |
|
|
2020
Q1 | $65M | Buy |
870,000
+409,400
| +89% | +$28.3M | 0.01% | 814 |
|
|
2019
Q4 | $29.9M | Buy |
460,600
+241,000
| +110% | +$15.7M | ﹤0.01% | 1542 |
|
|
2019
Q3 | $13.9M | Sell |
219,600
-48,500
| -18% | -$3.17M | ﹤0.01% | 2175 |
|
|
2019
Q2 | $18.1M | Sell |
268,100
-8,300
| -3% | -$546K | ﹤0.01% | 1956 |
|
|
2019
Q1 | $18M | Sell |
276,400
-861,400
| -76% | -$57.3M | ﹤0.01% | 1922 |
|
|
2018
Q4 | $71.2M | Buy |
1,137,800
+18,200
| +2% | +$1.27M | 0.01% | 821 |
|
|
2018
Q3 | $86.4M | Buy |
1,119,600
+40,200
| +4% | +$3.04M | 0.01% | 797 |
|
|
2018
Q2 | $76.5M | Sell |
1,079,400
-569,300
| -35% | -$40.2M | 0.01% | 830 |
|
|
2018
Q1 | $124M | Sell |
1,648,700
-1,138,500
| -41% | -$90.5M | 0.02% | 631 |
|
|
2017
Q4 | $200M | Buy |
2,787,200
+202,300
| +8% | +$15.4M | 0.03% | 448 |
|
|
2017
Q3 | $209M | Sell |
2,584,900
-184,000
| -7% | -$14.1M | 0.03% | 458 |
|
|
2017
Q2 | $196M | Buy |
2,768,900
+77,900
| +3% | +$5.18M | 0.04% | 431 |
|
|
2017
Q1 | $183M | Sell |
2,691,000
-135,500
| -5% | -$9.53M | 0.04% | 439 |
|
|
2016
Q4 | $202M | Buy |
2,826,500
+136,900
| +5% | +$10.2M | 0.04% | 408 |
|
|
2016
Q3 | $213M | Buy |
2,689,600
+506,600
| +23% | +$41.2M | 0.05% | 382 |
|
|
2016
Q2 | $182M | Buy |
2,183,000
+496,100
| +29% | +$44M | 0.04% | 416 |
|
|
2016
Q1 | $155M | Sell |
1,686,900
-203,700
| -11% | -$18.4M | 0.04% | 448 |
|
|
2015
Q4 | $191M | Sell |
1,890,600
-48,300
| -2% | -$5.03M | 0.05% | 413 |
|
|
2015
Q3 | $190M | Buy |
1,938,900
+187,500
| +11% | +$20.8M | 0.05% | 408 |
|
|
2015
Q2 | $205M | Buy |
1,751,400
+236,200
| +16% | +$25.8M | 0.07% | 311 |
|
|
2015
Q1 | $149M | Sell |
1,515,200
-1,455,700
| -49% | -$148M | 0.05% | 376 |
|
|
2014
Q4 | $280M | Buy |
2,970,900
+579,800
| +24% | +$60M | 0.1% | 229 |
|
|
2014
Q3 | $255M | Buy |
2,391,100
+510,200
| +27% | +$50M | 0.08% | 255 |
|
|
2014
Q2 | $156M | Buy |
1,880,900
+925,200
| +97% | +$72M | 0.05% | 397 |
|
|
2014
Q1 | $67.7M | Sell |
955,700
-677,300
| -41% | -$53.1M | 0.03% | 630 |
|
|
2013
Q4 | $123M | Sell |
1,633,000
-123,700
| -7% | -$8.61M | 0.04% | 421 |
|
|
2013
Q3 | $110M | Sell |
1,756,700
-121,300
| -6% | -$7.25M | 0.04% | 428 |
|
|
2013
Q2 | $96.3M | Buy |
+1,878,000
| New | +$97.9M | 0.04% | 430 |
|
Other funds holding GILD
VCM
VPM
Bank of America's GILD Position: Q1 2026 in Review
Bank of America reduced its Gilead Sciences (GILD) stake by 14% in Q1 2026, selling an estimated $440M and leaving 19,978,936 shares worth $2.78B. The position accounts for 0.2% of the portfolio, ranked #98.
Bank of America first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.84B in Q4 2025. 2,315 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Bank of America held 19,978,936 shares of Gilead Sciences worth $2.78B as of Q1 2026.
- Bank of America sold 3,142,684 Gilead Sciences shares in Q1 2026, an estimated $440M.
- Gilead Sciences made up 0.2% of Bank of America's portfolio in Q1 2026, its #98 holding.
- Bank of America first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Bank of America's Gilead Sciences position peaked at $2.84B in Q4 2025.
- 2,315 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.